Diagnostic Report: Final

DIAGNOSTIC REPORT
Patient Ref. No. 55000000659791
CLIENT CODE : C000137788
CLIENT'S NAME AND ADDRESS :

SOTHA MOHALLA COLLECTION CENTRE SRL Ltd
MOHALLA SOTHA SHAKEEL ROAD, DIST. BUDAUN, M/S A+ DIAGNOSTIC & HEALTH SERVICES,112 CIVIL LINES,
BUDAUN BAREILLY, 243001
BUDAUN 243601 UTTAR PRADESH, INDIA
UTTAR PRADESH INDIA Tel : 0581 - 2510777, 78, Fax :
8171473828 CIN - U74899PB1995PLC045956
Email : srlbly2002@yahoo.com, ccg.srlbly@gmail.com
PATIENT NAME : ICCHA PATIENT ID : ICCHF595115060
ACCESSION NO : 0055VF003701 AGE : 11 Years SEX : Female
DRAWN : 15/06/2022 14:15 RECEIVED : 15/06/2022 17:05 REPORTED : 15/06/2022 18:16
REFERRING DOCTOR : SELF CLIENT PATIENT ID :
Test Report Status Final Results Biological Reference Interval Units
KIDNEY CHECK
SERUM BLOOD UREA NITROGEN

BLOOD UREA NITROGEN 8 5 - 18 mg/dL
METHOD : SPECTROPHOTOMETRY
CREATININE, SERUM
CREATININE 1.00 High 0.30 - 0.70 mg/dL
URIC ACID, SERUM

URIC ACID 4.7 2.6 - 6.0 mg/dL
CALCIUM, SERUM
CALCIUM 8.8 8.8 - 10.8 mg/dL
PHOSPHORUS, SERUM
PHOSPHORUS 4.6 4.0 - 7.0 mg/dL
ALKALINE PHOSPHATASE, SERUM

ALKALINE PHOSPHATASE 136 130 - 560 U/L
TOTAL PROTEIN, SERUM

TOTAL PROTEIN 7.3 6.4 - 8.2 g/dL
ELECTROLYTES (NA/K/CL), SERUM

SODIUM 136 136 - 145 mmol/L
POTASSIUM 3.9 3.50 - 5.10 mmol/L
METHOD : ION SELECTIVE ELECTRODE TECHNOLOGY
CHLORIDE 107 98 - 107 mmol/L
LIVER CHECK
ALANINE AMINOTRANSFERASE, SERUM

ALANINE AMINOTRANSFERASE (ALT/SGPT) 34 < 34.0 U/L
ASPARTATE AMINOTRANSFERASE, SERUM

ASPARTATE AMINOTRANSFERASE (AST/SGOT) 48 High 15 - 37 U/L
Page 1 Of 5
Scan to View Details Scan to View Report

DIAGNOSTIC REPORT
Patient Ref. No. 55000000659791

8171473828 CIN - U74899PB1995PLC045956
BILIRUBIN (TOTAL, DIRECT, INDIRECT), SERUM

BILIRUBIN, TOTAL 0.31 0.3 - 1.2 mg/dL
BILIRUBIN, DIRECT 0.08 0.0 - 0.2 mg/dL

BILIRUBIN, INDIRECT 0.23 0.1 - 1.0 mg/dL

METHOD : CALCULATED PARAMETER
ALBUMIN, SERUM
ALBUMIN 3.5 3.4 - 5.0 g/dL
Interpretation(s)
SERUM BLOOD UREA NITROGEN-Causes of Increased levels
Pre renal
• High protein diet, Increased protein catabolism, GI haemorrhage, Cortisol, Dehydration, CHF Renal
• Renal Failure
Post Renal
• Malignancy, Nephrolithiasis, Prostatism
Causes of decreased levels

• Liver disease
• SIADH.
CREATININE, SERUM-Higher than normal level may be due to:
• Blockage in the urinary tract
• Kidney problems, such as kidney damage or failure, infection, or reduced blood flow
• Loss of body fluid (dehydration)
• Muscle problems, such as breakdown of muscle fibers
• Problems during pregnancy, such as seizures (eclampsia)), or high blood pressure caused by pregnancy (preeclampsia)
Lower than normal level may be due to:

• Myasthenia Gravis
• Muscular dystrophy
URIC ACID, SERUM-Causes of Increased levels
Dietary
• High Protein Intake.
• Prolonged Fasting,
• Rapid weight loss.
Gout
Lesch nyhan syndrome.
Type 2 DM.
Metabolic syndrome.
Causes of decreased levels

• Low Zinc Intake
• OCP’s
• Multiple Sclerosis
Nutritional tips to manage increased Uric acid levels

• Drink plenty of fluids
• Limit animal proteins
• High Fibre foods
• Vit C Intake
• Antioxidant rich foods
Page 2 Of 5

DIAGNOSTIC REPORT
Patient Ref. No. 55000000659791

8171473828 CIN - U74899PB1995PLC045956
CALCIUM, SERUM-Commom causes of decreased value of calcium (hypocalcemia) are chronic renal failure, hypomagnesemia and hypoalbuminemia.
Hypercalcemia (increased value of calcium) can be caused by increased intestinal absorbtion (vitamin d intoxication), increased skeletal reasorption
(immobilization), or a combination of mechanisms (primary hyperparathyroidism). Primary hyperparathyroidism and malignancy accounts for 90-95% of all cases of
hypercalcemia.
Values of total calcium is affected by serum proteins, particularly albumin thus, latter’s value should be taken into account when interpreting serum calcium
levels. The following regression equation may be helpful.
Corrected total calcium (mg/dl)= total calcium (mg/dl) + 0.8 (4- albumin [g/dl])*
because regression equations vary among group of patients in different physiological and pathological conditions, mathematical corrections are only
approximations. The possible mathematical corrections should be replaced by direct determination of free calcium by ISE (available with srl) a common and
important source of preanalytical error in the measurement of calcium is prolonged torniquet application during sampling. Thus, this along with fist clenching
should be avoided before phlebotomy.
ALKALINE PHOSPHATASE, SERUM-Alkaline phosphatase (ALP) is a protein found in almost all body tissues. Tissues with higher amounts of ALP include the liver, bile ducts,
and bone. Elevated Alkaline Phosphaqtase levels are seen in Biliary obstruction,Osteoblastic bone tumors, osteomalacia, hepatitis, Hyperparathyroidism,Leukemia,
Lymphoma,Paget''''''''s disease,Rickets,Sarcoidosis etc. Lower-than-normal ALP levels seen in Hypophosphatasia, Malnutrition, Protein deficiency,Wilson''''''''s disease .
TOTAL PROTEIN, SERUM-Serum total protein,also known as total protein, is a biochemical test for measuring the total amount of protein in serum..Protein in the plasma is
made up of albumin and globulin
Higher-than-normal levels may be due to: Chronic inflammation or infection, including HIV and hepatitis B or C, Multiple myeloma, Waldenstrom''''''''s disease
Lower-than-normal levels may be due to: Agammaglobulinemia, Bleeding (hemorrhage),Burns,Glomerulonephritis, Liver disease, Malabsorption, Malnutrition, Nephrotic
syndrome,Protein-losing enteropathy etc.
ELECTROLYTES (NA/K/CL), SERUM-ELECTROLYTES (NA/K/CL), SERUM
Sodium levels are Increased in dehydration, cushing''''''''s syndrome, aldosteronism & decreased in Addison''''''''s disease, hypopituitarism,liver disease. Hypokalemia (low K)
is common in vomiting, diarrhea, alcoholism, folic acid deficiency and primary aldosteronism. Hyperkalemia may be seen in end-stage renal failure, hemolysis, trauma,
Addison''''''''s disease, metabolic acidosis, acute starvation, dehydration, and with rapid K infusion.Chloride is increased in dehydration, renal tubular acidosis
(hyperchloremia metabolic acidosis), acute renal failure, metabolic acidosis associated with prolonged diarrhea and loss of sodium bicarbonate, diabetes insipidus,
adrenocortical hyperfuction, salicylate intoxication and with excessive infusion of isotonic saline or extremely high dietary intake of salt.Chloride is decreased in
overhydration, chronic respiratory acidosis, salt-losing nephritis, metabolic alkalosis, congestive heart failure, Addisonian crisis, certain types of metabolic acidosis,
persistent gastric secretion and prolonged vomiting,
ALANINE AMINOTRANSFERASE, SERUM-Alanine aminotransferase (ALT) test measures the amount of this enzyme in the blood. ALT is found mainly in the liver, but also in
smaller amounts in the kidneys, heart, muscles, and pancreas. It is commonly measured as a part of a diagnostic evaluation of hepatocellular injury, to determine liver
health. . AST levels increase during acute hepatitis, sometimes due to a viral infection, ischemia to the liver, chronic hepatitis, obstruction of bile ducts, cirrhosis.
ASPARTATE AMINOTRANSFERASE, SERUM-Aminotransferase (AST) is an enzyme found in various parts of the body .AST is found in the liver, heart, skeletal muscle,
kidneys, brain, and red blood cells, and it is commonly measured clinically as a marker for liver health. AST levels increase during chronic viral hepatitis, blockage of the
bile duct, cirrhosis of the liver, liver cancer, kidney failure, hemolytic anemia, pancreatitis, hemochromatosis. AST levels may also increase after a heart attack or strenuous
activity.
BILIRUBIN (TOTAL, DIRECT, INDIRECT), SERUM-BILIRUBIN (TOTAL, DIRECT, INDIRECT), SERUM
Bilirubin is a yellowish pigment found in bile and is a breakdown product of normal heme catabolism. Bilirubin is excreted in bile and urine, and elevated levels may give
yellow discoloration in jaundice.Elevated levels results from increased bilirubin production (eg, hemolysis and ineffective erythropoiesis), decreased bilirubin excretion (eg,
obstruction and hepatitis), and abnormal bilirubin metabolism (eg, hereditary and neonatal jaundice). Conjugated (direct) bilirubin is elevated more than unconjugated
(indirect) bilirubin in Viral hepatitis, Drug reactions, Alcoholic liver disease Conjugated (direct) bilirubin is also elevated more than unconjugated (indirect) bilirubin when
there is some kind of blockage of the bile ducts like in Gallstones getting into the bile ducts, tumors & Scarring of the bile ducts. Increased unconjugated (indirect) bilirubin
may be a result of Hemolytic or pernicious anemia, Transfusion reaction & a common metabolic condition termed Gilbert syndrome, due to low levels of the enzyme that
attaches sugar molecules to bilirubin.
Total Bili-
Source: Wallach"s Interpretation of Diagnostic tests, 9th ed
Direct Bili -
Source: Tietz Text book of Clinical Chemistry & Molecular Diagnostics, 4th ed
d
ALBUMIN, SERUM-Human serum albumin is the most abundant protein in human blood plasma. It is produced in the liver. Albumin constitutes about half of the blood serum
protein. Low blood albumin levels (hypoalbuminemia) can be caused by: Liver disease like cirrhosis of the liver, nephrotic syndrome, protein-losing enteropathy, Burns,
hemodilution, increased vascular permeability or decreased lymphatic clearance,malnutrition and wasting etc.
NEPHELOMETRY
C-REACTIVE PROTEIN, SERUM (QUANTITATIVE)
C-REACTIVE PROTEIN 2.1 0-3 mg/L
Page 3 Of 5

DIAGNOSTIC REPORT
Patient Ref. No. 55000000659791

8171473828 CIN - U74899PB1995PLC045956
Interpretation(s)
C-REACTIVE PROTEIN, SERUM (QUANTITATIVE)-CRP is one of the proteins commonly referred to as acute phase reactants. CRP is distinguished by its rapid response to
trauma or infection. Elevated levels of CRP may be seen in inflammatory disorders, tissue injury or necrosis and infections. Synthesis of CRP increases within 4-6 hours of
onset of inflammation, reaching peak values within 1-2 days. CRP levels also fall quickly after resolution of inflammation since its half life is 6 hours.
Testing for CRP is indicated in the following clinical situations - monitoring recovery from surgery, myocardial infarction, transplantation, inflammatory bowel disease,
rheumatic diseases and infectious diseases. Measuring and charting C-reactive protein values can also prove useful in determining disease progress or the effectiveness of
treatments.
CRP levels in autoimmune diseases may show little or no increase unless infection is present. Levels may not increase in conditions like pregnancy, angina, seizures,
asthma, common cold. The main limitation of CRP is in its non-specific response and should not be interpreted without a complete clinical history and evaluation.
**End Of Report**
Please visit www.srlworld.com for related Test Information for this accession
Dr. Mujeeb Ur Rehman, MD

Pathologist
Page 4 Of 5

DIAGNOSTIC REPORT
Patient Ref. No. 55000000659791

8171473828 CIN - U74899PB1995PLC045956
CONDITIONS OF LABORATORY TESTING & REPORTING

1. It is presumed that the test sample belongs to the patient 5. The results of a laboratory test are dependent on the
named or identified in the test requisition form. quality of the sample as well as the assay technology.
2. All Tests are performed and reported as per the 6. Result delays could be because of uncontrolled
turnaround time stated in the SRL Directory of services circumstances. e.g. assay run failure.
(DOS). 7. Tests parameters marked by asterisks are excluded from
3. SRL confirms that all tests have been performed or the “scope" of NABL accredited tests. (If laboratory is
assayed with highest quality standards, clinical safety & accredited).
technical integrity. 8. Laboratory results should be correlated with clinical
4. A requested test might not be performed if: information to determine Final diagnosis.
a. Specimen received is insufficient or inappropriate 9. Test results are not valid for Medico- legal purposes.
specimen quality is unsatisfactory 10. In case of queries or unexpected test results please call
b. Incorrect specimen type at SRL customer care (91115 91115). Post proper
c. Request for testing is withdrawn by the ordering doctor investigation repeat analysis may be carried out.
or patient
d. There is a discrepancy between the label on the
specimen container and the name on the test requisition
form
SRL Limited
Fortis Hospital, Sector 62, Phase VIII,
Mohali 160062
Page 5 Of 5

Diagnostic Report: Final

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Diagnostic Report: Final

Uploaded by

Copyright:

Available Formats

DIAGNOSTIC REPORT

Patient Ref. No. 55000000659791

CLIENT CODE : C000137788

CLIENT'S NAME AND ADDRESS :

PATIENT NAME : ICCHA PATIENT ID : ICCHF595115060

ACCESSION NO : 0055VF003701 AGE : 11 Years SEX : Female

DRAWN : 15/06/2022 14:15 RECEIVED : 15/06/2022 17:05 REPORTED : 15/06/2022 18:16

REFERRING DOCTOR : SELF CLIENT PATIENT ID :

Test Report Status Final Results Biological Reference Interval Units

SERUM BLOOD UREA NITROGEN

URIC ACID, SERUM

ALKALINE PHOSPHATASE, SERUM

TOTAL PROTEIN, SERUM

ELECTROLYTES (NA/K/CL), SERUM

CHLORIDE 107 98 - 107 mmol/L

ALANINE AMINOTRANSFERASE, SERUM

ASPARTATE AMINOTRANSFERASE, SERUM

Scan to View Details Scan to View Report

CLIENT CODE : C000137788

CLIENT'S NAME AND ADDRESS :

PATIENT NAME : ICCHA PATIENT ID : ICCHF595115060

ACCESSION NO : 0055VF003701 AGE : 11 Years SEX : Female

DRAWN : 15/06/2022 14:15 RECEIVED : 15/06/2022 17:05 REPORTED : 15/06/2022 18:16

REFERRING DOCTOR : SELF CLIENT PATIENT ID :

Test Report Status Final Results Biological Reference Interval Units

BILIRUBIN (TOTAL, DIRECT, INDIRECT), SERUM

BILIRUBIN, DIRECT 0.08 0.0 - 0.2 mg/dL

BILIRUBIN, INDIRECT 0.23 0.1 - 1.0 mg/dL

Causes of decreased levels

Lower than normal level may be due to:

Causes of decreased levels

Nutritional tips to manage increased Uric acid levels

Scan to View Details Scan to View Report

CLIENT CODE : C000137788

CLIENT'S NAME AND ADDRESS :

PATIENT NAME : ICCHA PATIENT ID : ICCHF595115060

ACCESSION NO : 0055VF003701 AGE : 11 Years SEX : Female

DRAWN : 15/06/2022 14:15 RECEIVED : 15/06/2022 17:05 REPORTED : 15/06/2022 18:16

REFERRING DOCTOR : SELF CLIENT PATIENT ID :

Test Report Status Final Results Biological Reference Interval Units

C-REACTIVE PROTEIN 2.1 0-3 mg/L

Scan to View Details Scan to View Report

CLIENT CODE : C000137788

CLIENT'S NAME AND ADDRESS :

PATIENT NAME : ICCHA PATIENT ID : ICCHF595115060

ACCESSION NO : 0055VF003701 AGE : 11 Years SEX : Female

DRAWN : 15/06/2022 14:15 RECEIVED : 15/06/2022 17:05 REPORTED : 15/06/2022 18:16

REFERRING DOCTOR : SELF CLIENT PATIENT ID :

Test Report Status Final Results Biological Reference Interval Units

Dr. Mujeeb Ur Rehman, MD

Scan to View Details Scan to View Report

CLIENT CODE : C000137788

CLIENT'S NAME AND ADDRESS :

PATIENT NAME : ICCHA PATIENT ID : ICCHF595115060

ACCESSION NO : 0055VF003701 AGE : 11 Years SEX : Female

DRAWN : 15/06/2022 14:15 RECEIVED : 15/06/2022 17:05 REPORTED : 15/06/2022 18:16

REFERRING DOCTOR : SELF CLIENT PATIENT ID :

Test Report Status Final Results Biological Reference Interval Units

CONDITIONS OF LABORATORY TESTING & REPORTING

Scan to View Details Scan to View Report

You might also like